E
Elliott M. Antman
Researcher at Brigham and Women's Hospital
Publications - 738
Citations - 187175
Elliott M. Antman is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 161, co-authored 716 publications receiving 179462 citations. Previous affiliations of Elliott M. Antman include Duke University & Katholieke Universiteit Leuven.
Papers
More filters
Journal Article
Abstract 3288: Association of Treatment with Non-Steroidal Anti-Inflammatory Agents (NSAIDS) on Study Entry with 30 Day Adverse Outcomes Among ST Elevation MI (STEMI) Patients Treated with a Fibrinolytic Agent. An EXTRACT-TIMI 25 Analysis
C. Michael Gibson,Sabina A. Murphy,Carolyn H. McCabe,David A. Morrow,Elliott M. Antman,Eugene Braunwald +5 more
TL;DR: In this article, the binding site of aspirin to platelet cyclooxygenase-1 (COX-1) was found to interfere with aspirin's cardioprotectiv...
Journal ArticleDOI
Biomarker Release After Percutaneous Coronary Intervention A Message From the Heart
TL;DR: Patients previously diagnosed with unstable angina are more properly diagnosed as having non–ST-elevation MI (NSTEMI) on the basis of the detection of elevated levels of cardiac troponins in their blood.
Journal ArticleDOI
Cardiac marker elevation after cardioversion: sorting out chicken and egg.
TL;DR: Clinicians need to consider three primary possible aetiologies for an elevated cardiac marker in the situation described above: (1) the elevated marker reflects an acute myocardial infarction as the cause of the arrhythmia, (2) the arrHythmia resulted in sufficient imbalance in myocardia oxygen supply and demand to result in acute my Cardiac Infarction, and (3) Electrical cardioversion or other resuscitative efforts caused myocardIAL damage.
Journal ArticleDOI
A strategy of using enoxaparin as adjunctive antithrombin therapy reduces death and recurrent myocardial infarction in patients who achieve early ST-segment resolution after fibrinolytic therapy: the ExTRACT-TIMI 25 ECG study
Benjamin M. Scirica,David A. Morrow,Zygmunt Sadowski,Mikhail Ruda,Jose C. Nicolau,Robert P. Giugliano,Stephen D. Wiviott,Marc S. Sabatine,Amy Shui,Elliott M. Antman,Eugene Braunwald +10 more
TL;DR: It is suggested that a strategy of ENOX improves outcomes by preventing re-occlusion in patients achieving initial successful reperfusion after fibrinolytic therapy rather than by facilitating initial reperfusions.
Journal ArticleDOI
Clinical practice guidelines for chronic cardiovascular disorders: a roadmap for the future.
Elliott M. Antman,Mariell Jessup +1 more
TL;DR: Clinicians want to provide their patients with the best possible advice with respect to the management of cardiovascular risk, often implementing evidence-based clinical practice guidelines designed to improve health outcomes.